{"organizations": [], "uuid": "8375b70e5ec3708a5f5aea6d5af51ee44b6e1fa5", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000551/device/rss", "section_title": "California", "url": "https://www.cnbc.com/2018/03/12/the-associated-press-peregrine-reports-3q-loss.html", "country": "US", "domain_rank": 767, "title": "Peregrine reports 3Q loss", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-13T00:01:00.000+02:00", "replies_count": 0, "uuid": "8375b70e5ec3708a5f5aea6d5af51ee44b6e1fa5"}, "author": "cnbc.com", "url": "https://www.cnbc.com/2018/03/12/the-associated-press-peregrine-reports-3q-loss.html", "ord_in_thread": 0, "title": "Peregrine reports 3Q loss", "locations": [], "entities": {"persons": [], "locations": [{"name": "tustin", "sentiment": "none"}, {"name": "calif.", "sentiment": "none"}, {"name": "tustin", "sentiment": "none"}], "organizations": [{"name": "peregrine pharmaceuticals inc.", "sentiment": "negative"}, {"name": "peregrine", "sentiment": "negative"}, {"name": "cdmo", "sentiment": "negative"}, {"name": "ap", "sentiment": "negative"}, {"name": "zacks investment research", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "TUSTIN, Calif. (AP) _ Peregrine Pharmaceuticals Inc. (CDMO) on Monday reported a loss of $11 million in its fiscal third quarter.\nOn a per-share basis, the Tustin, California-based company said it had a loss of 28 cents. Losses, adjusted to account for discontinued operations, came to 23 cents per share.\nThe pharmaceutical posted revenue of $6.8 million in the period.\nPeregrine expects full-year revenue in the range of $50 million to $55 million.\nIn the final minutes of trading on Monday, the company's shares hit $2.44. A year ago, they were trading at $4.56.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on CDMO at https://www.zacks.com/ap/CDMO", "external_links": [], "published": "2018-03-13T00:01:00.000+02:00", "crawled": "2018-03-13T03:37:58.000+02:00", "highlightTitle": ""}